Anaphylaxis to rocuronium.
Allen
S J
SJ
Royal Victoria Hospital, Belfast BT12 6BA, UK.
Gallagher
A
A
Paxton
L D
LD
D000322:Adrenergic Agonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced*; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D012151:Resuscitation / Q000379:methods; D012882:Skin Tests; D016896:Treatment Outcome; D014673:Vecuronium Bromide / Q000009:adverse effects* / Q000031:analogs & derivatives
D000322:Adrenergic Agonists; D003473:Neuromuscular Nondepolarizing Agents; D014673:Vecuronium Bromide; D004837:Epinephrine